We are pleased to announce that the Chinese Clinical Oncology (CCO) has attained its latest impact factor for the 2025 citation year: 2.7 (Figure 1).
Figure 1 Journal Impact Factor of CCO
Chinese Clinical Oncology (CCO; Chin Clin Oncol; Print ISSN 2304-3865; Online ISSN 2304-3873) is published by AME Publishing Company, with support from Wolters Kluwer (the journal content will be made available on Wolters Kluwer Health’s Lippincott and Ovid platforms). It is an Open Access, peer-reviewed, bimonthly journal (quarterly published from Sep 2012-Dec 2015). It has been indexed in MEDLINE/PubMed since 2014 and Web of Science [Emerging Sources Citation Index (ESCI)] since 2016. CCO publishes original articles, editorials, technical notes, case reports and reviews. The main focus of the journal is to describe new findings in the field of oncology and to provide current and practical information on diagnosis, prevention and clinical investigations of cancer. Specific areas of interest include, but are not limited to, multimodality therapy, markers, imaging, tumor biology, pathology, chemoprevention and technical advances related to cancer.
We strive to follow the best practices in publishing. The announcement of the journal’s latest impact factor is not only a significant achievement for the journal but also the recognition of its more significant scientific reach. Here, we would like to extend our heartfelt gratitude to all our Editorial Board Members, Guest Editors, Authors, and Reviewers for their significant contributions.
We look forward to the continuous cooperation with all the individuals mentioned above and those who are interested in cancer research to bring more exciting content to readers in the coming future.
2025 Journal Impact Factors of AME journals
We are also pleased to share the latest impact factors of all journals published under AME Publishing Company (Table 1).
- 37 AME journals received a Journal Impact Factor (JIF) this year, with three journals receiving their first JIF
- 12 journals have one or more categories ranked in Q1 or Q2
These achievements reflect the continuous growth and academic influence of our journal portfolio. We sincerely thank all contributors across our journals for their dedication and support.
Table 1 2025 Journal Impact Factors of AME journals
Editorial Office
Chinese Clinical Oncology